Translational control at the synapse: Role of RNA regulators

Trends in Biochemical Sciences

Volumn 38, Issue 1, 2013, Pages 47-55

  Iacoangeli, Anna ^a   Tiedge, Henri ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b SUNY Downstate Medical Center   (United States)

Author keywords

Local protein synthesis; Regulatory RNAs; Synapses; Translational control

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; INITIATION FACTOR 4A; MESSENGER RNA; METABOTROPIC RECEPTOR; SMALL NUCLEAR RNA;

FMR1 GENE; FRAGILE X SYNDROME; GENE; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE TARGETING; HUMAN; NERVE CELL; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; RNA BINDING; RNA TRANSPORT; SYNAPSE; TRANSLATION INITIATION; TRANSLATION REGULATION;

ANIMALS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; HUMANS; NEURONS; PROTEIN BIOSYNTHESIS; RNA; SYNAPSES;

EUKARYOTA;

EID: 84871504054     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2012.11.001     Document Type: Review

References (91)

1. Translational Control in Biology and Medicine 2007, Cold Spring Harbor Laboratory Press. M.B. Mathews (Ed.).
2. Tiedge H., Brosius J. Translational machinery in dendrites of hippocampal neurons in culture. J. Neurosci. 1996, 16:7171-7181.
3. Doyle M., Kiebler M.A. Mechanisms of dendritic mRNA transport and its role in synaptic tagging. EMBO J. 2011, 30:3540-3552.
4. Job C., Eberwine J. Localization and translation of mRNA in dendrites and axons. Nat. Rev. Neurosci. 2001, 2:889-898.
5. Kim J., et al. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:360-365.
6. Kosik K.S., Krichevsky A.M. The elegance of the microRNAs: a neuronal perspective. Neuron 2005, 47:779-782.
7. Schratt G.M., et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439:283-289.
8. Muddashetty R.S., et al. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol. Cell 2011, 42:673-688.
9. Im H.I., Kenny P.J. MicroRNAs in neuronal function and dysfunction. Trends Neurosci. 2012, 35:325-334.
10. Salta E., De Strooper B. Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol. 2012, 11:189-200.
11. Bassell G.J., Warren S.T. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 2008, 60:201-214.
12. Bear M.F., et al. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004, 27:370-377.
13. Hagerman R., et al. Fragile X and autism: intertwined at the molecular level leading to targeted treatments. Mol. Autism 2010, 1:12.
14. Laggerbauer B., et al. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 2001, 10:329-338.
15. Zalfa F., et al. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 2003, 112:317-327.
16. Monzo K., et al. Fragile X mental retardation protein controls trailer hitch expression and cleavage furrow formation in Drosophila embryos. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18160-18165.
17. Napoli I., et al. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 2008, 134:1042-1054.
18. Lacoux C., et al. BC1-FMRP interaction is modulated by 2'-O-methylation: RNA-binding activity of the tudor domain and translational regulation at synapses. Nucleic Acids Res. 2012, 40:4086-4096.
19. Weiler I.J., et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:5395-5400.
20. Ceman S., et al. Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum. Mol. Genet. 2003, 12:3295-3305.
21. Khandjian E.W., et al. Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:13357-13362.
22. Stefani G., et al. Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J. Neurosci. 2004, 24:7272-7276.
23. Darnell J.C., et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146:247-261.
24. Zalfa F., et al. FMRP binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA binding motif. J. Biol. Chem. 2005, 280:33403-33410.
25. Iacoangeli A., et al. On BC1 RNA and the fragile X mental retardation protein. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:734-739.
26. Schütt J., et al. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities. J. Biol. Chem. 2009, 284:25479-25487.
27. Gabus C., et al. The fragile X mental retardation protein has nucleic acid chaperone properties. Nucleic Acids Res. 2004, 32:2129-2137.
28. Amaral P.P., et al. The eukaryotic genome as an RNA machine. Science 2008, 319:1787-1789.
29. Cao X., et al. Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 2006, 29:77-103.
30. Mattick J.S. Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. Bioessays 2003, 25:930-939.
31. Mattick J.S. RNA regulation: a new genetics?. Nat. Rev. Genet. 2004, 5:316-323.
32. Djebali S., et al. Landscape of transcription in human cells. Nature 2012, 489:101-108.
33. Taft R.J., et al. The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays 2007, 29:288-299.
34. DeChiara T.M., Brosius J. Neural BC1 RNA: cDNA clones reveal nonrepetitive sequence content. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:2624-2628.
35. Kim J., et al. Transcription and processing of the rodent ID repeat family in germline and somatic cells. Nucleic Acids Res. 1995, 23:2245-2251.
36. Tiedge H., et al. Primary structure, neural-specific expression, and dendritic location of human BC200 RNA. J. Neurosci. 1993, 13:2382-2390.
37. Skryabin B.V., et al. The BC200 RNA gene and its neural expression are conserved in Anthropoidea (Primates). J. Mol. Evol. 1998, 47:677-685.
38. Martignetti J.A., Brosius J. BC200 RNA: a neural RNA polymerase III product encoded by a monomeric Alu element. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:11563-11567.
39. Ala domain into an extended stem-loop structure. RNA 2001, 7:722-730.
40. Martignetti J.A., Brosius J. Neural BC1 RNA as an evolutionary marker: guinea pig remains a rodent. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9698-9702.
41. Rozhdestvensky T.S., et al. Isolation and posttranscriptional modification analysis of native BC1 RNA from mouse brain. RNA Biol. 2007, 4:11-15.
42. Wang H., et al. Dendritic BC1 RNA: functional role in regulation of translation initiation. J. Neurosci. 2002, 22:10232-10241.
43. Kondrashov A.V., et al. Inhibitory effect of naked neural BC1 RNA or BC200 RNA on eukaryotic in vitro translation systems is reversed by poly(A)-binding protein (PABP). J. Mol. Biol. 2005, 353:88-103.
44. Eom T., et al. Dual nature of translational control by regulatory BC RNAs. Mol. Cell. Biol. 2011, 31:4538-4549.
45. Pestova T., et al. The mechanism of translation initiation in eukaryotes. Translational Control in Biology and Medicine 2007, 87-128. Cold Spring Harbor Laboratory Press. M.B. Mathews (Ed.).
46. Méthot N., et al. In vitro RNA selection identifies RNA ligands that specifically bind to eukaryotic translation initiation factor 4B: the role of the RNA recognition motif. RNA 1996, 2:38-50.
47. Huber K.M., et al. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 2000, 288:1254-1257.
48. Weiler I.J., et al. Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17504-17509.
49. Waung M.W., Huber K.M. Protein translation in synaptic plasticity: mGluR-LTD, Fragile X. Curr. Opin. Neurobiol. 2009, 19:319-326.
50. Chuang S.C., et al. Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J. Neurosci. 2005, 25:8048-8055.
51. Osterweil E.K., et al. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J. Neurosci. 2010, 30:15616-15627.
52. Ronesi J.A., Huber K.M. Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation. J. Neurosci. 2008, 28:543-547.
53. Zhong J., et al. BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. J. Neurosci. 2009, 29:9977-9986.
54. Zhong J., et al. Regulatory BC1 RNA and the fragile X mental retardation protein: convergent functionality in brain. PLoS ONE 2010, 5:e15509.
55. Lewejohann L., et al. Role of a neuronal small non-messenger RNA: behavioural alterations in BC1 RNA-deleted mice. Behav. Brain Res. 2004, 154:273-289.
56. Dictenberg J.B., et al. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev. Cell 2008, 14:926-939.
57. Schuman E.M., et al. Synaptic regulation of translation of dendritic mRNAs. J. Neurosci. 2006, 26:7143-7146.
58. Lescoute A., et al. Recurrent structural RNA motifs, isostericity matrices and sequence alignments. Nucleic Acids Res. 2005, 33:2395-2409.
59. Leontis N.B., et al. The building blocks and motifs of RNA architecture. Curr. Opin. Struct. Biol. 2006, 16:279-287.
60. The Nobel Prizes 2009 2010, Nobel Foundation. K. Grandin (Ed.).
61. Muslimov I.A., et al. Spatial codes in dendritic BC1 RNA. J. Cell Biol. 2006, 175:427-439.
62. Muslimov I.A., et al. Spatial code recognition in neuronal RNA targeting: role of RNA-hnRNP A2 interactions. J. Cell Biol. 2011, 194:441-457.
63. Smith R. Moving molecules: mRNA trafficking in mammalian oligodendrocytes and neurons. Neuroscientist 2004, 10:495-500.
64. Gao Y., et al. Multiplexed dendritic targeting of α calcium calmodulin-dependent protein kinase II, neurogranin, and activity-regulated cytoskeleton-associated protein RNAs by the A2 pathway. Mol. Biol. Cell 2008, 19:2311-2327.
65. Johnson E.M., et al. Role of Purα in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J. Neurosci. Res. 2006, 83:929-943.
66. Ohashi S., et al. The single-stranded DNA- and RNA-binding proteins pur α and pur β link BC1 RNA to microtubules through binding to the dendrite-targeting RNA motifs. J. Neurochem. 2000, 75:1781-1790.
67. Cao Z., et al. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum. Mol. Genet. 2012, 21:2923-2935.
68. Tassone F., et al. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 2000, 66:6-15.
69. Swanson M.S., Orr H.T. Fragile X tremor/ataxia syndrome: blame the messenger!. Neuron 2007, 55:535-537.
70. Iwahashi C.K., et al. Protein composition of the intranuclear inclusions of FXTAS. Brain 2006, 129:256-271.
71. Zumwalt M., et al. Secondary structure and dynamics of the r(CGG) repeat in the mRNA of the fragile X mental retardation 1 (FMR1) gene. RNA Biol. 2007, 4:93-100.
72. Napierala M., et al. Facile FMR1 mRNA structure regulation by interruptions in CGG repeats. Nucleic Acids Res. 2005, 33:451-463.
73. Sofola O.A., et al. RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 2007, 55:565-571.
74. Sellier C., et al. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J. 2010, 29:1248-1261.
75. Jin P., et al. Pur α binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 2007, 55:556-564.
76. Kim J., et al. Rodent BC1 RNA gene as a master for ID element amplification. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:3607-3611.
77. Buckley P.T., et al. Cytoplasmic intron sequence-retaining transcripts can be dendritically targeted via ID element retrotransposons. Neuron 2011, 69:877-884.
78. Khanam T., et al. Can ID repetitive elements serve as cis-acting dendritic targeting elements? An in vivo study. PLoS ONE 2007, 2:e961.
79. Pe'ery T., Mathews M.B. Viral translation strategies and host defense mechanisms. Translational Control of Gene Expression 2000, 400-424. Cold Spring Harbor Laboratory Press. N. Sonenberg (Ed.).
80. Kaufman R.J. The double-stranded RNA-activated protein kinase PKR. Translational Control of Gene Expression 2000, 503-527. Cold Spring Harbor Laboratory Press. N. Sonenberg (Ed.).
81. Bevilacqua P.C., et al. Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes. Biochemistry 1998, 37:6303-6316.
82. Cordaux R., Batzer M.A. The impact of retrotransposons on human genome evolution. Nat. Rev. Genet. 2009, 10:691-703.
83. Herbert A. The four Rs of RNA-directed evolution. Nat. Genet. 2004, 36:19-25.
84. Kazazian H.H. Mobile elements: drivers of genome evolution. Science 2004, 303:1626-1632.
85. Brosius J. Echoes from the past - are we still in an RNP world?. Cytogenet. Genome Res. 2005, 110:8-24.
86. Brosius J. Genomes were forged by massive bombardments with retroelements and retrosequences. Genetica 1999, 107:209-238.
87. De Koning A.P., et al. Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet. 2011, 7:e1002384.
88. Brosius J. Retroposons - seeds of evolution. Science 1991, 251:753.
89. Martignetti J.A., Brosius J. BC1 RNA: transcriptional analysis of a neural cell-specific RNA polymerase III transcript. Mol. Cell. Biol. 1995, 15:1642-1650.
90. Leontis N.B., et al. The non-Watson-Crick base pairs and their associated isostericity matrices. Nucleic Acids Res. 2002, 30:3497-3531.
91. Pang K.C., et al. Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet. 2006, 22:1-5.